E-LIB Suche - Ergebnisse für: Tournilhac, Olivier

1

Histological characterization of liver involvement in syste..:

Rossignol, Julien ; Canioni, Danielle ; Aouba, Achille...
Liver International. 44 (2024) 7 - p. 1680-1688 , 2024

Link: https://doi.org/10.1111/..

2

Faster clinical decisions in B‐cell acute lymphoblastic leu..:

Lebecque, Benjamin ; Besombes, Joevin ; Dannus, Louis‐Thomas...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

3

Pathophysiologic implications of elevated prevalence of her..:

Polivka, Laura ; Madrange, Marine ; Bulai-Livideanu, Cristina...
Journal of Allergy and Clinical Immunology. 153 (2024) 1 - p. 349-353.e4 , 2024

Link: https://doi.org/10.1016/..

4

Oral azacitidine compared with standard therapy in patients..:

Dupuis, Jehan ; Bachy, Emmanuel ; Morschhauser, Franck...
The Lancet Haematology. 11 (2024) 6 - p. e406-e414 , 2024

Link: https://doi.org/10.1016/..

5

Autologous hematopoietic cell transplantation for T-cell pr..:

Drozd-Sokolowska, Joanna ; Gras, Luuk ; Koster, Linda...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Molecular landscape of mature B‐cell lymphoproliferative di..:

Véronèse, Lauren ; Bensaber, Hedi ; Dannus, Louis‐Thomas...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

7

ABCL-450 Five-Year Efficacy and Safety of Tafasitamab in Pa..:

Duell, Johannes ; Abrisqueta, Pau ; Andre, Marc...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S433-S434 , 2023

Link: https://doi.org/10.1016/..

8

POSTER: ABCL-450 Five-Year Efficacy and Safety of Tafasitam..:

Duell, Johannes ; Abrisqueta, Pau ; Andre, Marc...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206 , 2023

Link: https://doi.org/10.1016/..

9

POSTER: ABCL-482 Five-Year Subgroup Analysis of Tafasitamab..:

Duell, Johannes ; Abrisqueta, Pau ; Dreyling, Martin...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206 , 2023

Link: https://doi.org/10.1016/..

10

Molecular characterization of Richter syndrome identifies d..:

Broséus, Julien ; Hergalant, Sébastien ; Vogt, Julia...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

del(8p) and TNFRSF10B loss are associated with a poor progn..:

Jondreville, Ludovic ; Dehgane, Lea ; Doualle, Cecile...
Leukemia. 37 (2023) 11 - p. 2221-2230 , 2023

Link: https://doi.org/10.1038/..

12

CD38 Targeting in Aggressive, Treatment-Refractory Cutaneou..:

Ta, Van Anh ; Battistella, Maxime ; Zhao, Lin Pierre...
Journal of Investigative Dermatology. 143 (2023) 7 - p. 1329-1332.e3 , 2023

Link: https://doi.org/10.1016/..

13

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTOR..:

Marouf, Amira ; Chaubard, Sammara ; Michot, Jean Marie...
HemaSphere. 7 (2023) S3 - p. e41118bf , 2023

Link: https://doi.org/10.1097/..

14

A fixed-duration immunochemotherapy approach in CLL: 5.5-ye..:

Michallet, Anne-Sophie ; Letestu, Rémi ; Le Garff-Tavernier, Magali...
Blood Advances. 7 (2023) 15 - p. 3936-3945 , 2023

Link: https://doi.org/10.1182/..

15

P596: DELETION OF THE SHORT ARM OF CHROMOSOME 8 AND TNFRSF1..:

Jondreville, Ludovic ; Dehgane, Lea ; Doualle, Cecile...
HemaSphere. 7 (2023) S3 - p. e37251a7 , 2023

Link: https://doi.org/10.1097/..